European Surveillance of Antimicrobial Consumption (ESAC): Outpatient penicillin use in Europe

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 2, 2006, Pages 408-412

  Ferech, Matus ^a   Coenen, Samuel ^a,b   Dvorakova, Katerina ^a   Hendrickx, Erik ^c   Suetens, Carl ^c   Goossens, Herman ^a,d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ambulatory care; Antibiotic use; Drug consumption; Europe; Penicillins; Pharmacoepidemiology

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZIDOCILLIN; AZLOCILLIN; BACAMPICILLIN; BETA LACTAMASE INHIBITOR; CARBENICILLIN; CARINDACILLIN; CLOXACILLIN; DICLOXACILLIN; EPICILLIN; HETACILLIN; MECILLINAM; METAMPICILLIN; METICILLIN; MEZLOCILLIN; PENAMECILLIN; PENICILLIN G; PENICILLIN V; PHENETICILLIN; PIPERACILLIN; PIVAMPICILLIN; PIVMECILLINAM; PROCAINE PENICILLIN; PROPICILLIN; SULBENICILLIN; TALAMPICILLIN; TEMOCILLIN; TICARCILLIN; UNINDEXED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; DRUG USE; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; OUTPATIENT CARE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION; EUROPE; HUMANS; OUTPATIENTS; PENICILLINS;

EID: 33748066641     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl186     Document Type: Article

References (8)

1. World Health Organization. Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs. Oslo, Norway: WHO, 2005.
2. Ferech M, Coenen S, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient antibiotic use in Europe. J Antimicrob Chemother 2006; 58: 401-7.
3. Vander Stichele R, Elseviers M, Ferech M et al. European surveillance of antimicrobial consumption (ESAC): Data collection performance and methodological approach. Br J Clin Pharmacol 2004; 58: 419-28.
4. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005; 365: 579-87.
5. Loffeld A, Davies P, Lewis A et al. Seasonal occurrence of impetigo: A retrospective 8-year review (1996-2003). Clin Exp Dermatol 2005; 30: 512-4.
6. Aguilar L, Giménez ML, García-Rey C et al. New strategies to overcome antimicrobial resistance in Streptococcus pneumoniae with β-lactam antibiotics. J Antimicrob Chemother 2002; 50 Suppl S2: 93-100.
7. Joint Formulary Committee. British National Formulary. 50th edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2005. http://www.bnf.org (22 November 2005, date last accessed).
8. Ferech M, Hendrickx E, Mittermayer H et al. Critical assessment of the volume of systemic outpatient use of penicillins (P) in Europe. In: Abstracts of the Forty-fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2004. Abstract 0-1610, p. 444. American Society for Microbiology, Washington, DC, USA.